Filing Details

Accession Number:
0001562180-19-005642
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-22 06:20:19
Reporting Period:
2019-11-20
Accepted Time:
2019-11-22 06:20:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1517022 Akebia Therapeutics Inc. AKBA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1379970 C Steven Gilman C/o Akebia Therapeutics, Inc.
245 First St.
Cambridge MA 02142
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-20 5,800 $3.43 29,731 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchase reported in this Form 4 was made on the open market.